Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.500
-0.060 (-2.34%)
At close: Apr 1, 2025, 4:00 PM
2.650
+0.150 (6.00%)
After-hours: Apr 1, 2025, 4:48 PM EDT
Ensysce Biosciences Employees
As of December 31, 2024, Ensysce Biosciences had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year.
Employees
8
Change (1Y)
1
Growth (1Y)
14.29%
Revenue / Employee
$651,254
Profits / Employee
-$998,403
Market Cap
3.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8 | 1 | 14.29% |
| Dec 31, 2023 | 7 | 0 | - |
| Dec 31, 2022 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | 3 | 100.00% |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ENSC News
- 1 day ago - Ensysce Biosciences, Inc. Announces $1.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Accesswire
- 14 days ago - Ensysce Biosciences Announces PAINWeek 2025 Symposium and Recent Expert Panel Discussion on The State of the Nation in Pain - Accesswire
- 22 days ago - Ensysce Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results - Accesswire
- 27 days ago - Ensysce Biosciences to Participate in the 37th Annual ROTH Conference - Accesswire
- 4 weeks ago - Ensysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation Opioids - PRNewsWire
- 7 weeks ago - Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comments on Current Landscape for Pain Treatment - Accesswire
- 2 months ago - Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR - Accesswire
- 2 months ago - Ensysce Biosciences Issues Annual Shareholder Letter - Accesswire